HADV (Health Advance) Equity-to-Asset: 0.91 (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Advance Equity-to-Asset?

Health Advance HADV Equity-to-Asset is 0.91 as of Sep. 2017.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Health Advance's Total Stockholders Equity for the quarter that ended in Sep. 2017 was $2.68 Mil. Health Advance's Total Assets for the quarter that ended in Sep. 2017 was $2.97 Mil.

The historical rank and industry rank for Health Advance's Equity-to-Asset or its related term are showing as below:

HADV's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.485
* Ranked among companies with meaningful Equity-to-Asset only.

Health Advance  (OTCPK:HADV) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Health Advance Equity-to-Asset Related Terms

Health Advance Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Health Advance's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Advance Equity-to-Asset Chart

Health Advance Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15
Equity-to-Asset
0.62 -16.50 -63.00 0.00 0.00

Health Advance Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Sep17
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.91

HADV vs MYDP, HEWA, RXMD: Equity-to-Asset Comparison

For the Pharmaceutical Retailers subindustry, Health Advance's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Advance Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Advance's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Health Advance's Equity-to-Asset falls into.


Health Advance Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Health Advance's Equity to Asset Ratio for the fiscal year that ended in Jul. 2015 is calculated as

Equity to Asset (A: Jul. 2015 )=Total Stockholders Equity/Total Assets
=-0.13/0
=

Health Advance's Equity to Asset Ratio for the quarter that ended in Sep. 2017 is calculated as

Equity to Asset (Q: Sep. 2017 )=Total Stockholders Equity/Total Assets
=2.682/2.965
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.91 mean?
Health Advance (HADV) has a Equity-to-Asset of 0.91 as of Sep. 2017. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Health Advance and its competitors.
Is Health Advance's Equity-to-Asset too high?
Health Advance's current Equity-to-Asset is 0.91. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Health Advance's value of 0.91 is 87.6% above this industry median.
How does Health Advance's Equity-to-Asset compare to MYDP and HEWA?
Health Advance's Equity-to-Asset of 0.91 can be compared against companies in the Healthcare Providers & Services industry. The industry median Equity-to-Asset is 0.49. Health Advance's value of 0.91 is 87.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Advance's current Equity-to-Asset of 0.91 is 87.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Health Advance and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Advance's current Equity-to-Asset is 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Advance stock overvalued right now?
Health Advance (HADV) has a current Equity-to-Asset of 0.91. The current Equity-to-Asset is 0.91 and 87.6% above the Healthcare Providers & Services industry median of 0.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Health Advance (HADV), the current Equity-to-Asset is 0.91 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Advance Business Description

Address 9131 Keele Street, Suite A4, Vaughan, ON, CAN, L4K 0G7
Health Advance Inc is engaged in the retail domain. The Company is focused on products that are oriented to health and wellness. The first example of this is a proprietary CBD-infused wine beverage. The company is in the analysis stage for Immune boosting nutraceuticals, and human wellness products.